Aprexis Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 2

Aprexis General Information


Developer of cloud-based medication management software designed to revolutionize the delivery of medication management and treatment therapy. The company's software provides assistance to manage consistent and effective quality medication to reduce the cost of care, improve health outcomes and increase patient satisfaction, enabling pharmacists and providers to recommend changes in regimen.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Primary Office
  • 85 Granite Shed Lane
  • Unit 1
  • Montpelier, VT 05602
  • United States
+1 (802) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aprexis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 26-Jun-2012 $4M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Aug-2011 00000 00000 00.000 Completed Generating Revenue
To view Aprexis’s complete valuation and funding history, request access »

Aprexis Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Aprexis’s complete cap table history, request access »

Aprexis Executive Team (5)

Name Title Board Seat Contact Info
Nancy Bundek Ph.D Co-Founder, Senior Vice President of Clinical Development & President
Robert Squire Co-Founder, Board Member & President
Michael Howe Co-Founder & Managing Partner
Sandra Wright Senior Vice President, Product Development
You’re viewing 4 of 5 executive team members. Get the full list »

Aprexis Board Members (4)

Name Representing Role Since
David Bradbury VCET Capital Board Member 000 0000
Robert Squire Aprexis Co-Founder, Board Member & President 000 0000
Robert Sullivan Aprexis Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Aprexis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aprexis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CMS Group (France) Corporation 000 0000 000000 0
VCET Capital Accelerator/Incubator Minority 000 0000 000000 0
To view Aprexis’s complete investors history, request access »